Clinical development and drug safety teams are faced with many challenges in the form of growing necessity to create personalized medicine, reducing clinical trial cycle times, improving compliance to drug safety and privacy, timely & accurate monitoring and reporting of the safety profile of products and complex marketing, co-development and other partnership arrangements.

Optimization of IT investments is the primary focus of top pharmaceutical manufacturers. The efforts are directed towards facilitation of real-time communication and visibility between the R&D and marketing sectors.

With Life science companies very much dependent on the sales and marketing force, the major hurdles they face involve streamlining the various communication channels, low perceived product differentiation, regulatory constraints, diverse customer needs and issues related to access to the physician community and non-physician customers.